Growth Metrics

Haemonetics (HAE) Receivables - Net (2016 - 2025)

Haemonetics has reported Receivables - Net over the past 16 years, most recently at $195.7 million for Q4 2025.

  • For Q4 2025, Receivables - Net fell 7.66% year-over-year to $195.7 million; the TTM value through Dec 2025 reached $195.7 million, down 7.66%, while the annual FY2025 figure was $202.7 million, 1.89% down from the prior year.
  • Receivables - Net for Q4 2025 was $195.7 million at Haemonetics, down from $207.1 million in the prior quarter.
  • Over five years, Receivables - Net peaked at $213.5 million in Q3 2024 and troughed at $127.6 million in Q2 2021.
  • A 5-year average of $179.9 million and a median of $180.1 million in 2022 define the central range for Receivables - Net.
  • Biggest five-year swings in Receivables - Net: dropped 22.79% in 2021 and later increased 24.95% in 2022.
  • Year by year, Receivables - Net stood at $141.3 million in 2021, then grew by 28.16% to $181.1 million in 2022, then rose by 16.85% to $211.6 million in 2023, then increased by 0.16% to $211.9 million in 2024, then dropped by 7.66% to $195.7 million in 2025.
  • Business Quant data shows Receivables - Net for HAE at $195.7 million in Q4 2025, $207.1 million in Q3 2025, and $200.8 million in Q2 2025.